首页 > 最新文献

Surgery for Obesity and Related Diseases最新文献

英文 中文
The value of patient selection in same-day discharge implementation: insights from MBSAQIP database 患者选择在当日出院实施中的价值:来自MBSAQIP数据库的见解。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2025-11-10 DOI: 10.1016/j.soard.2025.10.016
Sara Saeidishahri M.D., Amir Ebadinejad M.D., Yin Wu Ph.D., Tara McLaughlin Ph.D., Edward Hannoush M.D., F.A.C.S., Dale Bond Ph.D., Darren Tishler M.D., F.A.C.S., F.A.S.M.B.S., Pavlos Papasavas M.D.

Background

Same-day discharge (SDD) in sleeve gastrectomy (SG) is becoming increasingly common but requires careful patient selection.

Objectives

To evaluate the risk profile of patients undergoing primary SG with SDD and assess 30-day serious adverse events (SAEs) in SDD and next-day discharge (NDD).

Setting

MBSAQIP 2020-2023 (United States).

Methods

SDD and NDD patients were categorized as low-risk (LR) [age<65 years, body mass index [BMI] <50 kg/m2, and no history of foregut surgery, diabetes, sleep apnea, cardiovascular disease, kidney disease, immunosuppression or thromboembolic events], and high-risk (HR) [patients with at least one of these conditions]. Logistic regression models assessed odds of SAE (i.e., Comprehensive Complication Index ≥26.2) between SDD and NDD based on risk categories and cumulative number of risk factors (RFs).

Results

Forty thousand three hundred eighty-seven SDDs (50.4% LR, 49.6% HR) and 281,718 NDD (41.2% LR, 58.8% HR) were identified. The odds of HR patients experiencing SAE were higher in the SDD versus NDD (odds ratio [OR]: 1.26, confidence interval [CI]: 1.09-1.45, P < .001). Among high-risk SDD, 66.9% patients had one RF, 25.7% had two and 7.4% had ≥ 3. Compared to patients with a single RF, those with 2 RFs and ≥3RFs were more likely to experience SAEs (OR = 1.40 and 2.10, respectively; P < .01).

Conclusions

This study demonstrates that 50% of the SDD SG patients were considered high-risk and 32% had multiple RFs. Performing SG with SDD in high-risk patients is associated with a greater likelihood of SAE. Results warrant implementation of risk stratification models to ensure patient safety while maximizing the benefits of SDD.
背景:套筒胃切除术(SG)中的当日出院(SDD)越来越普遍,但需要仔细选择患者。目的:评估原发性SG合并SDD患者的风险概况,评估SDD患者30天严重不良事件(SAEs)和次日出院(NDD)。设定:MBSAQIP 2020-2023(美国)。方法:SDD和NDD患者被分为低危(LR)[年龄2岁,无前肠手术、糖尿病、睡眠呼吸暂停、心血管疾病、肾脏疾病、免疫抑制或血栓栓塞事件史]和高危(HR)[至少有上述一种情况的患者]。Logistic回归模型根据风险类别和累积风险因素(RFs)评估SDD和NDD之间发生SAE的几率(即综合并发症指数≥26.2)。结果:共检出sdd 40387份(LR 50.4%, HR 49.6%), NDD 281718份(LR 41.2%, HR 58.8%)。HR患者发生SAE的几率在SDD组高于NDD组(优势比[OR]: 1.26,可信区间[CI]: 1.09-1.45, P < .001)。在高危SDD患者中,66.9%的患者有1次RF, 25.7%有2次RF, 7.4%有≥3次RF。与单次RF患者相比,2次RF和≥3次RF患者更容易发生SAEs (OR分别= 1.40和2.10;P < 0.01)。结论:本研究表明,50%的SDD SG患者被认为是高风险的,32%的患者有多发RFs。高危患者行SG合并SDD与更大的SAE可能性相关。结果表明,需要实施风险分层模型,以确保患者安全,同时最大限度地提高SDD的效益。
{"title":"The value of patient selection in same-day discharge implementation: insights from MBSAQIP database","authors":"Sara Saeidishahri M.D.,&nbsp;Amir Ebadinejad M.D.,&nbsp;Yin Wu Ph.D.,&nbsp;Tara McLaughlin Ph.D.,&nbsp;Edward Hannoush M.D., F.A.C.S.,&nbsp;Dale Bond Ph.D.,&nbsp;Darren Tishler M.D., F.A.C.S., F.A.S.M.B.S.,&nbsp;Pavlos Papasavas M.D.","doi":"10.1016/j.soard.2025.10.016","DOIUrl":"10.1016/j.soard.2025.10.016","url":null,"abstract":"<div><h3>Background</h3><div>Same-day discharge (SDD) in sleeve gastrectomy (SG) is becoming increasingly common but requires careful patient selection.</div></div><div><h3>Objectives</h3><div>To evaluate the risk profile of patients undergoing primary SG with SDD and assess 30-day serious adverse events (SAEs) in SDD and next-day discharge (NDD).</div></div><div><h3>Setting</h3><div>MBSAQIP 2020-2023 (United States).</div></div><div><h3>Methods</h3><div>SDD and NDD patients were categorized as low-risk (LR) [age&lt;65 years, body mass index [BMI] &lt;50 kg/m<sup>2</sup>, and no history of foregut surgery, diabetes, sleep apnea, cardiovascular disease, kidney disease, immunosuppression or thromboembolic events], and high-risk (HR) [patients with at least one of these conditions]. Logistic regression models assessed odds of SAE (i.e., Comprehensive Complication Index ≥26.2) between SDD and NDD based on risk categories and cumulative number of risk factors (RFs).</div></div><div><h3>Results</h3><div>Forty thousand three hundred eighty-seven SDDs (50.4% LR, 49.6% HR) and 281,718 NDD (41.2% LR, 58.8% HR) were identified. The odds of HR patients experiencing SAE were higher in the SDD versus NDD (odds ratio [OR]: 1.26, confidence interval [CI]: 1.09-1.45, <em>P</em> &lt; .001). Among high-risk SDD, 66.9% patients had one RF, 25.7% had two and 7.4% had ≥ 3. Compared to patients with a single RF, those with 2 RFs and ≥3RFs were more likely to experience SAEs (OR = 1.40 and 2.10, respectively; <em>P</em> &lt; .01).</div></div><div><h3>Conclusions</h3><div>This study demonstrates that 50% of the SDD SG patients were considered high-risk and 32% had multiple RFs. Performing SG with SDD in high-risk patients is associated with a greater likelihood of SAE. Results warrant implementation of risk stratification models to ensure patient safety while maximizing the benefits of SDD.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 3","pages":"Pages 324-329"},"PeriodicalIF":3.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Society of Metabolic and Bariatric Surgery review of gut microbiome and alterations related to weight loss treatment, by the Clinical Issues Committee 美国代谢与减肥外科学会临床问题委员会对与减肥治疗相关的肠道微生物组和改变的综述。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2025-12-09 DOI: 10.1016/j.soard.2025.11.021
Brandon T. Grover D.O, F.A.C.S., F.A.S.M.B.S. , Salvatore Docimo Jr. D.O. M.B.A., F.A.C.S., F.A.S.M.B.S. , Thomas H. Shin M.D., PhD. , Timothy Shope M.D., F.A.C.S., F.A.S.M.B.S , Vance L. Albaugh M.D., PhD., F.A.C.S., F.A.S.M.B.S , Rachel Byers M.P.H. , Heather Passerini N.P , C. Joe Northup M.D., F.A.C.S., F.A.S.M.B.S. , R. Wesley Vosburg M.D., F.A.C.S., F.A.S.M.B.S.
The gut microbiome is a critical mediator of metabolic health including obesity and type 2 diabetes. Microbial composition variation — driven by diet, genetics, environment, and host physiology — can influence insulin sensitivity, energy absorption, fat storage, and systemic inflammation. Metabolic and bariatric surgery (MBS) is associated with distinct shifts in gut microbiota that may contribute to weight loss and metabolic improvements. Changes in microbial diversity, bile acid metabolism, and enrichment of beneficial taxa have all been linked to favorable metabolic outcomes. Furthermore, the gut microbiome may interact with molecular signaling pathways including glucagon-like peptide-1 signaling. Despite probiotics and prebiotics showing potential modulation of the gut microbiota, their clinical impact on obesity management remains inconsistent. Understanding the complex interplay between MBS, the gut microbiome, and host metabolism may offer novel insights into future therapeutic targets. As the field advances, microbiome-based strategies may enhance procedure selection, improve patient outcomes after MBS, and contribute to more personalized, durable treatment approaches for obesity and its related diseases.
肠道微生物群是代谢健康的重要媒介,包括肥胖和2型糖尿病。微生物组成的变化——由饮食、遗传、环境和宿主生理驱动——可以影响胰岛素敏感性、能量吸收、脂肪储存和全身炎症。代谢和减肥手术(MBS)与肠道微生物群的明显变化有关,这可能有助于减轻体重和改善代谢。微生物多样性的变化、胆汁酸代谢和有益类群的富集都与有利的代谢结果有关。此外,肠道微生物组可能与分子信号通路相互作用,包括胰高血糖素样肽-1信号通路。尽管益生菌和益生元显示出肠道微生物群的潜在调节作用,但它们对肥胖管理的临床影响仍不一致。了解MBS、肠道微生物组和宿主代谢之间复杂的相互作用可能为未来的治疗靶点提供新的见解。随着该领域的发展,基于微生物组的策略可能会加强手术选择,改善MBS后患者的预后,并有助于为肥胖及其相关疾病提供更个性化、更持久的治疗方法。
{"title":"American Society of Metabolic and Bariatric Surgery review of gut microbiome and alterations related to weight loss treatment, by the Clinical Issues Committee","authors":"Brandon T. Grover D.O, F.A.C.S., F.A.S.M.B.S. ,&nbsp;Salvatore Docimo Jr. D.O. M.B.A., F.A.C.S., F.A.S.M.B.S. ,&nbsp;Thomas H. Shin M.D., PhD. ,&nbsp;Timothy Shope M.D., F.A.C.S., F.A.S.M.B.S ,&nbsp;Vance L. Albaugh M.D., PhD., F.A.C.S., F.A.S.M.B.S ,&nbsp;Rachel Byers M.P.H. ,&nbsp;Heather Passerini N.P ,&nbsp;C. Joe Northup M.D., F.A.C.S., F.A.S.M.B.S. ,&nbsp;R. Wesley Vosburg M.D., F.A.C.S., F.A.S.M.B.S.","doi":"10.1016/j.soard.2025.11.021","DOIUrl":"10.1016/j.soard.2025.11.021","url":null,"abstract":"<div><div>The gut microbiome is a critical mediator of metabolic health including obesity and type 2 diabetes. Microbial composition variation — driven by diet, genetics, environment, and host physiology — can influence insulin sensitivity, energy absorption, fat storage, and systemic inflammation. Metabolic and bariatric surgery (MBS) is associated with distinct shifts in gut microbiota that may contribute to weight loss and metabolic improvements. Changes in microbial diversity, bile acid metabolism, and enrichment of beneficial taxa have all been linked to favorable metabolic outcomes. Furthermore, the gut microbiome may interact with molecular signaling pathways including glucagon-like peptide-1 signaling. Despite probiotics and prebiotics showing potential modulation of the gut microbiota, their clinical impact on obesity management remains inconsistent. Understanding the complex interplay between MBS, the gut microbiome, and host metabolism may offer novel insights into future therapeutic targets. As the field advances, microbiome-based strategies may enhance procedure selection, improve patient outcomes after MBS, and contribute to more personalized, durable treatment approaches for obesity and its related diseases.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 3","pages":"Pages 317-323"},"PeriodicalIF":3.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145866971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SOARD Category 1 CME Credit Featured Articles, Volume 22, March 2026 SOARD第一类CME信用专题文章,第22卷,2026年3月
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2026-02-14 DOI: 10.1016/j.soard.2026.02.001
{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 22, March 2026","authors":"","doi":"10.1016/j.soard.2026.02.001","DOIUrl":"10.1016/j.soard.2026.02.001","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 3","pages":"Pages 380-382"},"PeriodicalIF":3.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146192975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of resleeve gastrectomy after primary sleeve gastrectomy: a MBSAQIP analysis of perioperative risk 一期套筒胃切除术后缓解性胃切除术的预后:MBSAQIP围手术期风险分析。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-02-01 Epub Date: 2025-11-01 DOI: 10.1016/j.soard.2025.10.010
Pattharasai Kachornvitaya M.D. , Valentin Mocanu M.D., Ph.D. , Mélissa V. Wills M.D. , Juan S. Barajas-Gamboa M.D. , Xinlei Zhu M.D. , Ricard Corcelles M.D., Ph.D. , Andrew Strong M.D. , Suthep Udomsawaengsup M.D. , Matthew Kroh M.D. , Jerry Dang M.D., Ph.D. , Salvador Navarrete M.D.

Background

Resleeve gastrectomy (ReSG) is a surgical option for patients experiencing insufficient weight loss or weight regain after primary sleeve gastrectomy (P-SG). However, national-level data on the comparative perioperative safety of ReSG versus P-SG remain limited.

Objectives

To evaluate 30-day perioperative outcomes between ReSG and P-SG.

Setting

Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database across accredited bariatric surgical centers.

Methods

An analysis of the 2020–2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database was conducted to evaluate 30-day outcomes following ReSG. Univariate analysis and multivariable logistic regression identified independent predictors of serious postoperative complications.

Results

Among 496,405 patients, 493,187 underwent P-SG and 3218 underwent ReSG. ReSG patients were older, more likely female, and had a higher prevalence of gastroesophageal reflux disease but lower body mass index and comorbidity burden. ReSG was associated with significantly higher rates of serious complications (5.13% versus 2.03%, P < .0001), including anastomotic leak, deep surgical site infection, and the need for reintervention. Multivariable analysis identified ReSG as the strongest independent predictor of serious complications (odds ratio: 2.26), followed by anticoagulant use, history of venous thromboembolism, insulin-dependent diabetes, hypertension, gastroesophageal reflux disease, and Black race. Mortality was low and comparable between groups (P = .360).

Conclusions

ReSG is associated with significantly higher rates of serious perioperative complications compared to P-SG despite similar short-term mortality. These findings underscore the importance of revisional strategy selection and alternative procedures may offer superior safety, more durable weight loss, and improved metabolic outcomes for revision after sleeve gastrectomy.
背景:缓解式胃切除术(ReSG)是原发性袖式胃切除术(P-SG)后体重减轻或体重恢复不足的患者的一种手术选择。然而,关于ReSG与P-SG围手术期安全性比较的国家级数据仍然有限。目的:评价ReSG和P-SG之间围手术期30天的预后。环境:分析经过认证的减肥手术中心的代谢和减肥手术认证和质量改进计划数据库。方法:对2020-2023年代谢和减肥手术认证和质量改进计划数据库进行分析,评估ReSG后30天的结果。单因素分析和多变量logistic回归确定了严重术后并发症的独立预测因素。结果:496405例患者中,493187例接受P-SG, 3218例接受ReSG。ReSG患者年龄较大,更可能是女性,胃食管反流病患病率较高,但体重指数和合并症负担较低。ReSG与严重并发症发生率(5.13%比2.03%,P < 0.0001)相关,包括吻合口瘘、深部手术部位感染和再次干预的需要。多变量分析发现,ReSG是严重并发症的最强独立预测因子(优势比:2.26),其次是抗凝剂使用、静脉血栓栓塞史、胰岛素依赖性糖尿病、高血压、胃食管反流病和黑人。死亡率较低,组间具有可比性(P = 0.360)。结论:与P-SG相比,ReSG的严重围手术期并发症发生率明显更高,尽管短期死亡率相似。这些发现强调了修复策略选择的重要性,替代手术可能提供更好的安全性,更持久的体重减轻,并改善袖胃切除术后修复的代谢结果。
{"title":"Outcomes of resleeve gastrectomy after primary sleeve gastrectomy: a MBSAQIP analysis of perioperative risk","authors":"Pattharasai Kachornvitaya M.D. ,&nbsp;Valentin Mocanu M.D., Ph.D. ,&nbsp;Mélissa V. Wills M.D. ,&nbsp;Juan S. Barajas-Gamboa M.D. ,&nbsp;Xinlei Zhu M.D. ,&nbsp;Ricard Corcelles M.D., Ph.D. ,&nbsp;Andrew Strong M.D. ,&nbsp;Suthep Udomsawaengsup M.D. ,&nbsp;Matthew Kroh M.D. ,&nbsp;Jerry Dang M.D., Ph.D. ,&nbsp;Salvador Navarrete M.D.","doi":"10.1016/j.soard.2025.10.010","DOIUrl":"10.1016/j.soard.2025.10.010","url":null,"abstract":"<div><h3>Background</h3><div>Resleeve gastrectomy (ReSG) is a surgical option for patients experiencing insufficient weight loss or weight regain after primary sleeve gastrectomy (P-SG). However, national-level data on the comparative perioperative safety of ReSG versus P-SG remain limited.</div></div><div><h3>Objectives</h3><div>To evaluate 30-day perioperative outcomes between ReSG and P-SG.</div></div><div><h3>Setting</h3><div>Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database across accredited bariatric surgical centers.</div></div><div><h3>Methods</h3><div>An analysis of the 2020–2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database was conducted to evaluate 30-day outcomes following ReSG. Univariate analysis and multivariable logistic regression identified independent predictors of serious postoperative complications.</div></div><div><h3>Results</h3><div>Among 496,405 patients, 493,187 underwent P-SG and 3218 underwent ReSG. ReSG patients were older, more likely female, and had a higher prevalence of gastroesophageal reflux disease but lower body mass index and comorbidity burden. ReSG was associated with significantly higher rates of serious complications (5.13% versus 2.03%, <em>P</em> &lt; .0001), including anastomotic leak, deep surgical site infection, and the need for reintervention. Multivariable analysis identified ReSG as the strongest independent predictor of serious complications (odds ratio: 2.26), followed by anticoagulant use, history of venous thromboembolism, insulin-dependent diabetes, hypertension, gastroesophageal reflux disease, and Black race. Mortality was low and comparable between groups (<em>P</em> = .360).</div></div><div><h3>Conclusions</h3><div>ReSG is associated with significantly higher rates of serious perioperative complications compared to P-SG despite similar short-term mortality. These findings underscore the importance of revisional strategy selection and alternative procedures may offer superior safety, more durable weight loss, and improved metabolic outcomes for revision after sleeve gastrectomy.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 2","pages":"Pages 234-241"},"PeriodicalIF":3.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145663095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cartoon Feb 2026 2026年2月
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-02-01 Epub Date: 2025-12-01 DOI: 10.1016/j.soard.2025.11.018
{"title":"Cartoon Feb 2026","authors":"","doi":"10.1016/j.soard.2025.11.018","DOIUrl":"10.1016/j.soard.2025.11.018","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 2","pages":"Page 308"},"PeriodicalIF":3.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146015820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paired editorial: perioperative safety profile of single anastomosis duodeno-ileal bypass and Roux-en-Y gastric bypass after sleeve gastrectomy 配对编辑:套筒胃切除术后单吻合术十二指肠回肠旁路和Roux-en-Y胃旁路围手术期安全性分析。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-02-01 Epub Date: 2025-10-10 DOI: 10.1016/j.soard.2025.10.003
Francesco Palazzo M.D., F.A.C.S., F.A.S.M.B.S.
{"title":"Paired editorial: perioperative safety profile of single anastomosis duodeno-ileal bypass and Roux-en-Y gastric bypass after sleeve gastrectomy","authors":"Francesco Palazzo M.D., F.A.C.S., F.A.S.M.B.S.","doi":"10.1016/j.soard.2025.10.003","DOIUrl":"10.1016/j.soard.2025.10.003","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 2","pages":"Pages e1-e2"},"PeriodicalIF":3.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145447025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Society for Metabolic and Bariatric Surgery systematic review of literature surrounding support groups and metabolic and bariatric surgery 美国代谢与减肥外科学会对支持团体和代谢与减肥手术相关文献的系统综述。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-02-01 Epub Date: 2025-10-31 DOI: 10.1016/j.soard.2025.10.008
Andrea Rigby Psy.D., M.E.D. , Ninoska D. Peterson Ph.D. , Lillian Craggs-Dino D.H.A., R.D.N., L.D.N. , Larissa A. McGarrity Ph.D. , Laura Aylward Ph.D.
Patients seeking metabolic and bariatric surgery (MBS) are treated by an interdisciplinary team of surgeons and integrated health professionals before and after their surgery. Support groups are required as part of safety and quality of care programs seeking and maintaining accreditation; nevertheless, the research is limited regarding the efficacy and outcomes related to support group attendance. The intention of this systematic review is to summarize current literature surrounding MBS support groups, to identify gaps in the literature, and to provide recommendations for future research regarding support groups, as well as guidance for support group facilitators. Using Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines platform and database searches were conducted for MBS support groups from 1998 to present using PubMed (Medline); Ovid (Medline); APA PsycNet (PsychINFO). Inclusion criteria were English language, adults of any age and adolescents (ages 14-18), and private, hospital, or academic medical center live support groups that follow American Society for Metabolic and Bariatric Surgery standards. Eighteen studies were included in our review. Authors sought to examine the relationship between attendance at facilitator-led, in person or virtual and hybrid support groups and outcomes of weight loss, self-management, and barriers to attendance. Results showed that support group attendance was associated with better weight loss, self-management, and adherence following surgery. This review supports the ongoing need for support group to be part of the interdisciplinary care of patients undergoing MBS. Additional research is needed to address cited gaps in the literature surrounding selection bias, lack of comparison groups, and to determine the impact of hybrid and virtual support groups on patient outcomes.
寻求代谢和减肥手术(MBS)的患者在手术前和术后由外科医生和综合卫生专业人员组成的跨学科团队进行治疗。作为安全和质量护理项目的一部分,需要支持团体寻求和维持认证;然而,关于支持小组出勤的有效性和结果的研究是有限的。本系统综述的目的是总结当前关于MBS支持小组的文献,找出文献中的空白,并为未来关于支持小组的研究提供建议,以及为支持小组促进者提供指导。使用首选报告项目进行系统评价和荟萃分析指南,使用PubMed (Medline)对1998年至今的MBS支持小组进行了平台和数据库搜索;奥维德(Medline);APA心理网(PsychINFO)。纳入标准为英语,任何年龄的成年人和青少年(14-18岁),以及遵循美国代谢和减肥外科学会标准的私人、医院或学术医疗中心现场支持团体。我们的综述纳入了18项研究。作者试图研究参加辅导员领导的、亲自或虚拟和混合支持小组与减肥、自我管理和出席障碍的结果之间的关系。结果显示,参加支持小组与手术后更好的减肥、自我管理和依从性有关。本综述支持支持小组作为MBS患者跨学科护理的一部分的持续需求。需要进一步的研究来解决文献中关于选择偏倚的空白,缺乏对照组,并确定混合和虚拟支持小组对患者结果的影响。
{"title":"American Society for Metabolic and Bariatric Surgery systematic review of literature surrounding support groups and metabolic and bariatric surgery","authors":"Andrea Rigby Psy.D., M.E.D. ,&nbsp;Ninoska D. Peterson Ph.D. ,&nbsp;Lillian Craggs-Dino D.H.A., R.D.N., L.D.N. ,&nbsp;Larissa A. McGarrity Ph.D. ,&nbsp;Laura Aylward Ph.D.","doi":"10.1016/j.soard.2025.10.008","DOIUrl":"10.1016/j.soard.2025.10.008","url":null,"abstract":"<div><div>Patients seeking metabolic and bariatric surgery (MBS) are treated by an interdisciplinary team of surgeons and integrated health professionals before and after their surgery. Support groups are required as part of safety and quality of care programs seeking and maintaining accreditation; nevertheless, the research is limited regarding the efficacy and outcomes related to support group attendance. The intention of this systematic review is to summarize current literature surrounding MBS support groups, to identify gaps in the literature, and to provide recommendations for future research regarding support groups, as well as guidance for support group facilitators. Using Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines platform and database searches were conducted for MBS support groups from 1998 to present using PubMed (Medline); Ovid (Medline); APA PsycNet (PsychINFO). Inclusion criteria were English language, adults of any age and adolescents (ages 14-18), and private, hospital, or academic medical center live support groups that follow American Society for Metabolic and Bariatric Surgery standards. Eighteen studies were included in our review. Authors sought to examine the relationship between attendance at facilitator-led, in person or virtual and hybrid support groups and outcomes of weight loss, self-management, and barriers to attendance. Results showed that support group attendance was associated with better weight loss, self-management, and adherence following surgery. This review supports the ongoing need for support group to be part of the interdisciplinary care of patients undergoing MBS. Additional research is needed to address cited gaps in the literature surrounding selection bias, lack of comparison groups, and to determine the impact of hybrid and virtual support groups on patient outcomes.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 2","pages":"Pages 189-197"},"PeriodicalIF":3.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bariatric conversional surgery in younger adults ≤40: who gets converted and comparative risks of conversion to subsequent procedures ≤40岁的年轻人的减肥转换手术:谁得到了转换和转换到后续手术的比较风险。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-02-01 Epub Date: 2025-11-10 DOI: 10.1016/j.soard.2025.10.013
Jeremy Peabody M.D. , Sukhdeep Jatana M.D.C.M. , Kevin Verhoeff M.D., Ph.D. , Valentin Mocanu M.D., Ph.D. , Daniel W. Birch M.D., M.Sc. , Shahzeer Karmali M.D. , Noah J. Switzer M.D., M.P.H.

Background

The incidence of bariatric surgery in younger adults, and subsequently conversional surgery, is increasing.

Objectives

We aim to describe patients ≤40 requiring conversion, operative details, and complications associated with different procedures.

Setting

MBSAQIP centers (United States and Canada).

Methods

We included patients ≤40 years from 2020 to 2022 undergoing a conversion procedure to sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), single anastomosis duodeno-ileal bypass (SADI-S), or biliopancreatic diversion-duodenal switch (BPD/DS). Baseline characteristics and bivariate complication rates were compared. Multivariate models were generated for 30-day complication for all patients undergoing conversion surgery from index adjustable gastric banding (AGB) or SG.

Results

Of 13,486 patients, 842 were converted to SG, 9812 to RYGB, 549 to SADI-S, and 2283 to BPD/DS. The most common reason for conversion to RYGB was gastroesophageal reflux disease (GERD) (48.7%) and to SADI-S and BPD/DS was insufficient weight loss/regain (89.6% and 88.1%, respectively). On multivariate analysis, conversion to RYGB (adjusted odds ratio [aOR] 2.14) and BPD/DS (aOR 2.30) were associated with increased risk compared to SG. After controlling for initial operation, conversion of AGB to RYGB had a higher likelihood of having 30-day serious complication compared to SG (aOR 2.18). For patients with an index SG, conversion to BPD/DS carried similar likelihood of 30-day complication to RYGB (aOR .78, P = .302), while conversion to SADI-S carried lower likelihood (aOR .47, P = .031).

Conclusion

Each conversion surgery is associated with differing rates of complications, and conversion from index AGB to SG versus RYGB and from index SG to SADI-S versus RYGB or BPD/DS may be associated with fewer complications.
背景:年轻人减肥手术以及随后的转换手术的发生率正在增加。目的:我们的目的是描述≤40的患者需要转换,手术细节和不同手术相关的并发症。环境:MBSAQIP中心(美国和加拿大)。方法:我们纳入了2020年至2022年≤40岁的患者,他们接受了套管胃切除术(SG)、Roux-en-Y胃旁路术(RYGB)、单吻合术十二指肠-回肠旁路术(SADI-S)或胆胰分流-十二指肠开关术(BPD/DS)的转换手术。比较基线特征和双因素并发症发生率。对所有接受指数可调节胃束带(AGB)或SG转换手术的患者进行30天并发症的多变量模型。结果:13486例患者中,842例转为SG, 9812例转为RYGB, 549例转为SADI-S, 2283例转为BPD/DS。转为RYGB的最常见原因是胃食管反流病(GERD)(48.7%),而转为SADI-S和BPD/DS的最常见原因是体重减轻/恢复不足(分别为89.6%和88.1%)。在多变量分析中,与SG相比,转为RYGB(调整比值比[aOR] 2.14)和BPD/DS (aOR 2.30)与风险增加相关。在控制初始手术后,与SG相比,AGB转换为RYGB发生30天严重并发症的可能性更高(aOR 2.18)。对于指数为SG的患者,转换为BPD/DS的30天并发症的可能性与RYGB (aOR)相似。78, P = .302),而转化为SADI-S的可能性较低(aOR)。47, p = 0.031)。结论:每种转换手术的并发症发生率不同,从AGB指数到SG指数与RYGB相比,从SG指数到SADI-S指数与RYGB或BPD/DS相比,并发症可能较少。
{"title":"Bariatric conversional surgery in younger adults ≤40: who gets converted and comparative risks of conversion to subsequent procedures","authors":"Jeremy Peabody M.D. ,&nbsp;Sukhdeep Jatana M.D.C.M. ,&nbsp;Kevin Verhoeff M.D., Ph.D. ,&nbsp;Valentin Mocanu M.D., Ph.D. ,&nbsp;Daniel W. Birch M.D., M.Sc. ,&nbsp;Shahzeer Karmali M.D. ,&nbsp;Noah J. Switzer M.D., M.P.H.","doi":"10.1016/j.soard.2025.10.013","DOIUrl":"10.1016/j.soard.2025.10.013","url":null,"abstract":"<div><h3>Background</h3><div>The incidence of bariatric surgery in younger adults, and subsequently conversional surgery, is increasing.</div></div><div><h3>Objectives</h3><div>We aim to describe patients ≤40 requiring conversion, operative details, and complications associated with different procedures.</div></div><div><h3>Setting</h3><div>MBSAQIP centers (United States and Canada).</div></div><div><h3>Methods</h3><div>We included patients ≤40 years from 2020 to 2022 undergoing a conversion procedure to sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), single anastomosis duodeno-ileal bypass (SADI-S), or biliopancreatic diversion-duodenal switch (BPD/DS). Baseline characteristics and bivariate complication rates were compared. Multivariate models were generated for 30-day complication for all patients undergoing conversion surgery from index adjustable gastric banding (AGB) or SG.</div></div><div><h3>Results</h3><div>Of 13,486 patients, 842 were converted to SG, 9812 to RYGB, 549 to SADI-S, and 2283 to BPD/DS. The most common reason for conversion to RYGB was gastroesophageal reflux disease (GERD) (48.7%) and to SADI-S and BPD/DS was insufficient weight loss/regain (89.6% and 88.1%, respectively). On multivariate analysis, conversion to RYGB (adjusted odds ratio [aOR] 2.14) and BPD/DS (aOR 2.30) were associated with increased risk compared to SG. After controlling for initial operation, conversion of AGB to RYGB had a higher likelihood of having 30-day serious complication compared to SG (aOR 2.18). For patients with an index SG, conversion to BPD/DS carried similar likelihood of 30-day complication to RYGB (aOR .78, <em>P</em> = .302), while conversion to SADI-S carried lower likelihood (aOR .47, <em>P</em> = .031).</div></div><div><h3>Conclusion</h3><div>Each conversion surgery is associated with differing rates of complications, and conversion from index AGB to SG versus RYGB and from index SG to SADI-S versus RYGB or BPD/DS may be associated with fewer complications.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 2","pages":"Pages 255-263"},"PeriodicalIF":3.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart failure is a major risk factor for postoperative venous thromboembolism in bariatric surgery patients 心力衰竭是减肥手术患者术后静脉血栓栓塞的主要危险因素。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-02-01 Epub Date: 2025-10-30 DOI: 10.1016/j.soard.2025.10.007
Zubaidah Nor Hanipah , Florina Corpodean , Michael Kachmar , Michael R. Cook , Vance L. Albaugh , Philip R. Schauer

Background

Identifying preoperative comorbidities predictive of postoperative thromboembolic events (e.g. deep vein thrombosis, DVT; pulmonary embolism, PE), may help target higher-risk patients for preventive measures. In 2023, the Metabolic and Bariatric Surgery Quality Improvement Project (MBSAQIP) began capturing preoperative heart failure, a known risk factor for DVT/PE.

Objectives

This study aimed to analyze the 2023 database to identify and rank preoperative factors including heart failure that are most strongly associated with postoperative DVT/PE risk in patients undergoing metabolic and bariatric surgery (MBS).

Setting

Metabolic and Bariatric Surgery Quality Improvement Project (MBSAQIP).

Methods

The 2023 MBSAQIP was queried (n = 217,952) and multivariable logistic regression modeling was used to assess factors predictive of postoperative DVT and PE, adjusting for demographics, preoperative comorbidities, and surgical factors.

Results

After a history of prior DVT/PE, a history of heart failure was associated with the second highest odds ratio (OR) for postoperative thromboembolic events (OR: 1.73 [95% CI: 1.12-2.57, P < .01). Other significant risk factors venous thromboembolism (VTE) included older age, higher BMI, male sex, liver disease, and gastroesophageal reflux disease (GERD). Non-revisional (i.e. primary) surgery and therapeutic anticoagulation were identified as factors associated with risk reduction.

Conclusions

This large retrospective analysis demonstrated that patients with a history of heart failure are nearly 2 times as likely to develop VTE after bariatric surgery compared to those with no history of heart failure. Patients with a history of heart failure should be considered high risk for VTE and should be considered for similar VTE prophylaxis as patients with prior DVT/PE.
背景:确定预测术后血栓栓塞事件的术前合并症(如深静脉血栓形成,DVT;肺栓塞,PE),可能有助于针对高危患者采取预防措施。2023年,代谢和减肥手术质量改善项目(MBSAQIP)开始捕捉术前心力衰竭,这是DVT/PE的已知危险因素。目的:本研究旨在分析2023数据库,以确定包括心力衰竭在内的术前因素,这些因素与接受代谢和减肥手术(MBS)的患者术后DVT/PE风险最密切相关。单位:代谢与减肥手术质量改善项目(MBSAQIP)。方法:查询2023 MBSAQIP (n = 217,952),采用多变量logistic回归模型评估预测术后DVT和PE的因素,调整人口统计学、术前合并症和手术因素。结果:在既往DVT/PE病史之后,心力衰竭史与术后血栓栓塞事件的第二高优势比(OR: 1.73 [95% CI: 1.12-2.57, P < 0.01)相关。静脉血栓栓塞(VTE)的其他重要危险因素包括年龄较大、BMI较高、男性、肝脏疾病和胃食管反流病(GERD)。非修正(即原发性)手术和治疗性抗凝治疗被确定为与风险降低相关的因素。结论:这项大型回顾性分析表明,有心力衰竭病史的患者在减肥手术后发生静脉血栓栓塞的可能性是没有心力衰竭病史的患者的近2倍。有心力衰竭病史的患者应被认为是静脉血栓栓塞的高风险患者,并应考虑与既往DVT/PE患者类似的静脉血栓栓塞预防措施。
{"title":"Heart failure is a major risk factor for postoperative venous thromboembolism in bariatric surgery patients","authors":"Zubaidah Nor Hanipah ,&nbsp;Florina Corpodean ,&nbsp;Michael Kachmar ,&nbsp;Michael R. Cook ,&nbsp;Vance L. Albaugh ,&nbsp;Philip R. Schauer","doi":"10.1016/j.soard.2025.10.007","DOIUrl":"10.1016/j.soard.2025.10.007","url":null,"abstract":"<div><h3>Background</h3><div>Identifying preoperative comorbidities predictive of postoperative thromboembolic events (e.g. deep vein thrombosis, DVT; pulmonary embolism, PE), may help target higher-risk patients for preventive measures. In 2023, the Metabolic and Bariatric Surgery Quality Improvement Project (MBSAQIP) began capturing preoperative heart failure, a known risk factor for DVT/PE.</div></div><div><h3>Objectives</h3><div>This study aimed to analyze the 2023 database to identify and rank preoperative factors including heart failure that are most strongly associated with postoperative DVT/PE risk in patients undergoing metabolic and bariatric surgery (MBS).</div></div><div><h3>Setting</h3><div>Metabolic and Bariatric Surgery Quality Improvement Project (MBSAQIP).</div></div><div><h3>Methods</h3><div>The 2023 MBSAQIP was queried (n = 217,952) and multivariable logistic regression modeling was used to assess factors predictive of postoperative DVT and PE, adjusting for demographics, preoperative comorbidities, and surgical factors.</div></div><div><h3>Results</h3><div>After a history of prior DVT/PE, a history of heart failure was associated with the second highest odds ratio (OR) for postoperative thromboembolic events (OR: 1.73 [95% CI: 1.12-2.57, <em>P</em> &lt; .01). Other significant risk factors venous thromboembolism (VTE) included older age, higher BMI, male sex, liver disease, and gastroesophageal reflux disease (GERD). Non-revisional (i.e. primary) surgery and therapeutic anticoagulation were identified as factors associated with risk reduction.</div></div><div><h3>Conclusions</h3><div>This large retrospective analysis demonstrated that patients with a history of heart failure are nearly 2 times as likely to develop VTE after bariatric surgery compared to those with no history of heart failure. Patients with a history of heart failure should be considered high risk for VTE and should be considered for similar VTE prophylaxis as patients with prior DVT/PE.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 2","pages":"Pages 198-205"},"PeriodicalIF":3.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The unasked questions in MBS innovation: from physiological plausibility to patient safety MBS创新中未被问及的问题:从生理上的合理性到患者安全。
IF 3.8 3区 医学 Q1 SURGERY Pub Date : 2026-02-01 Epub Date: 2025-11-21 DOI: 10.1016/j.soard.2025.11.016
Francesco Saverio Papadia M.D., F.A.C.S., F.E.B.S. (SurgOnc)
{"title":"The unasked questions in MBS innovation: from physiological plausibility to patient safety","authors":"Francesco Saverio Papadia M.D., F.A.C.S., F.E.B.S. (SurgOnc)","doi":"10.1016/j.soard.2025.11.016","DOIUrl":"10.1016/j.soard.2025.11.016","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 2","pages":"Pages 301-302"},"PeriodicalIF":3.8,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery for Obesity and Related Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1